Pharvaris (PHVS) CEO Berndt Modig Sells 2,291 Shares

What Happened

• Berndt Modig, CEO of Pharvaris N.V. (PHVS), sold 2,291 shares on 2026-09-14 at a reported weighted-average price of $39.40, generating proceeds of approximately $90,276. According to the filing, these shares were acquired upon vesting of restricted stock units (RSUs) and then sold pursuant to a Rule 10b5-1 trading plan.

Key Details

• Transaction date: 2026-09-14; filing date (Form 4): 2026-09-15 (appears timely; Form 4 is generally due within two business days).
• Reported price: $39.40 (weighted average). Footnote indicates the sales on the reported date occurred in multiple transactions with prices ranging $38.69–$40.39; the filer can provide a breakdown on request.
• Proceeds: ~$90,276 for the 2,291 shares sold.
• Reason/notes: F1 — shares were RSUs that vested and were sold under a Rule 10b5-1 plan. F2 — some shares sold on the date were in connection with a cashless exercise of options; the filing reports a weighted-average sale price and a price range. F3 — Schoodic Management BV is an entity controlled by Mr. Modig (disclosed in the filing).
• Shares owned after the transaction: Not specified in the provided filing excerpt.

Context

• This sale follows RSU vesting and was executed under a pre-established Rule 10b5-1 plan, which is common for insiders to sell shares on an automated schedule and does not by itself indicate a change in the insider’s view of the company. The filing also references a cashless exercise component for some of the shares sold that same day; cashless exercises typically result in immediate sale of shares to cover option costs and withholding.